Auvelity: New Oral Fast Acting Antidepressant FDA Approved for MDD

  Рет қаралды 16,431

Psychiatry Education Forum

Psychiatry Education Forum

Күн бұрын

On Aug 19, 2022 Axsome Therapeutics announced the FDA Approval of Auvelity, as the first and Only Oral NMDA Receptor Antagonist for the treatment of Major Depressive Disorder in adults.
(CORRECTION: In the mechanism section, it is SIGMA RECEPTOR AGONISM & NOT ANTAGONISM)
We have summarized this FDA-approved medication in the following
Psychiatry Education Forum Academy Updates:
Read Details: psychiatryeducationforum.com/...

Пікірлер
Auvelity: What you NEED to know!
10:16
Levelheaded Mind
Рет қаралды 13 М.
DELETE TOXICITY = 5 LEGENDARY STARR DROPS!
02:20
Brawl Stars
Рет қаралды 14 МЛН
Gepirone (Exxua): New Antidepressant FDA Approved for MDD
16:42
Psychiatry Education Forum
Рет қаралды 2,1 М.
Wellbutrin (bupropion) Works for ADHD
30:51
Dr. John Kruse
Рет қаралды 17 М.
Auvelity: Side Effects
1:00
Levelheaded Mind
Рет қаралды 661
High Yield Internal Medicine Review for Step 2 CK & Shelf Exam
3:12:39
Doctor High Yield, MD
Рет қаралды 624 М.
GAD: Initial Medication of Choice?
22:17
Psychiatry Education Forum
Рет қаралды 10 М.